Concepedia

Sarah Kammerer

SK

20

Publications

609

Citations

15

H-Index

2014

Active since

Affiliations

Brandenburg University of Technology Cottbus-Senftenberg(Current)

Fraunhofer Institute for Cell Therapy and Immunology

Medical University of Graz

Charles University

University of Hradec Králové

Sarah Kammerer is an author at Brandenburg University of Technology Cottbus-Senftenberg specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2014–2023

20

Publications

20

Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line

Chouyang Li, Simin Rezania, Sarah Kammerer et al. · Scientific Reports · 2015 · 164 citations · Full text

ATP-based cell viability assay is superior to trypan blue exclusion and XTT assay in measuring cytotoxicity of anticancer drugs Taxol and Imatinib, and proteasome inhibitor MG-132 on human hepatoma cell line HepG2

Elisabeth Nowak, Sarah Kammerer, Jan‐Heiner Küpper · Clinical Hemorheology and Microcirculation · 2018 · 48 citations

Human hepatocyte systems for in vitro toxicology analysis

Sarah Kammerer, Jan‐Heiner Küpper · Journal of Cellular Biotechnology · 2018 · 47 citations · Full text

Abdominal and pelvic CT: is positive enteric contrast still necessary? Results of a retrospective observational study

Sarah Kammerer, Anna Janina Höink, Hauke Heinzow et al. · European Radiology · 2014 · 39 citations

, , +9

Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR

Sue Ellen Verbrugge, Marjon Al, Yehuda G. Assaraf et al. · Oncotarget · 2015 · 30 citations · Full text

Rows per page

1–5 of 20